Body

Swine flu patients benefited from taking Tamiflu, says study

Healthy people who caught swine flu during the 2009 pandemic may have been protected against developing radiographically (x-ray) confirmed pneumonia by taking the antiviral drug oseltamivir (Tamiflu), concludes a study of cases in China published on bmj.com today.

The researchers also show that oseltamivir treatment was associated with shorter duration of fever and viral RNA shedding (the period when a virus is contagious), although they stress that their findings should be interpreted with caution.

Absent mothers can cause hyperactivity and anxiety later in life

In mice, early weaning and separation from their mothers promotes long-lasting hyperactivity and anxiety . Researchers writing in the open access journal BMC Neuroscience describe the development of this new behavioral model, which they hope to use to investigate the long-term effects of early childhood neglect in people.

New study shows over one-fifth of the world's plants are under threat of extinction

A global analysis of extinction risk for the world's plants, conducted by the Royal Botanic Gardens, Kew together with the Natural History Museum, London and the International Union for the Conservation of Nature (IUCN), has revealed that the world's plants are as threatened as mammals, with one in five of the world's plant species threatened with extinction.

Nanotechnology brings personalized therapy 1 step closer to reality

DENVER — A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.

Gaining back pounds after weight loss? Hit the gym to double health benefit

COLUMBIA, Mo. – Although obesity is a major risk factor for disease, much of the threat may be associated with the metabolic (or cardiometabolic) syndrome, a cluster of risk factors related to diabetes and heart disease. Losing weight can improve health and reduce many of these risk factors. However, many people struggle to keep the weight off long-term. Now, researchers at the University of Missouri have found that people who perform resistance training while regaining weight can help maintain strides in reducing their risks for chronic disease.

Chest physiotherapy not effective in infants hospitalized with acute bronchiolitis

In research published this week in PLoS Medicine, Vincent Gajdos and colleagues report the results of a randomized trial conducted among hospitalized infants with bronchiolitis. The researchers enrolled nearly 500 children aged 15 days to 2 years who were admitted to seven French hospitals for a first episode of acute bronchiolitis. Their results show that a physiotherapy technique (increased exhalation and assisted cough) commonly used in France does not reduce time to recovery in this population.

19-million-year-old genomic fossils of hepatitis B-like viruses in songbirds

Biologists from The University of Texas at Arlington have uncovered virus fragments from the same family of the modern Hepatitis B virus locked inside the genomes of songbirds such as the modern-day zebra finch. The article, publishing next week in the online, open access journal PLoS Biology, marks the first time that endogenous hepadnaviruses have been found in any organism. An endogenous virus is one that deposits itself or fragments of itself into the chromosome of an organism, allowing it to be passed from generation-to-generation.

Sodium plays key role in tissue regeneration

Sodium plays key role in tissue regeneration

Pharma must be held more accountable to its human rights responsibilities

In this week's PLoS Medicine, the Editors argue that drug companies should be held much more accountable for their human rights responsibilities to make medicines available and accessible to those in need. Despite decades of advocacy on the part of the access to medicines movement, and human rights guidelines developed in 2008 for pharmaceutical companies that make clear that their responsibilities go beyond stakeholder value to encompass human rights, there is inadequate accountability, say the Editors.

Genome inversion gives plant a new lifestyle

DURHAM, N.C. – The yellow monkeyflower, an unassuming little plant that lives as both a perennial on the foggy coasts of the Pacific Northwest and a dry-land annual hundreds of miles inland, harbors a significant clue about evolution.

Sparkling drinks spark pain circuits

You may not think of the fizz in soda as spicy, but your body does.

The carbon dioxide in fizzy drinks sets off the same pain sensors in the nasal cavity as mustard and horseradish, though at a lower intensity, according to new research from the University of Southern California.

"Carbonation evokes two distinct sensations. It makes things sour and it also makes them burn. We have all felt that noxious tingling sensation when soda goes down your throat too fast," said Emily Liman, senior author of a study published online in the Journal of Neuroscience.

New VARI findings next step to growing drought-resistant plants

Grand Rapids, Mich. (September 28, 2010) – New findings from Van Andel Research Institute (VARI) scientists could lead to environmentally-friendly sprays that help plants survive drought and other stresses in harsh environments to combat global food shortages. The study is a follow-up to findings published in Nature last year that were named among the top breakthroughs of 2009 by Science magazine.

African-Americans equally likely to benefit from erlotinib and other targeted lung cancer therapy

DENVER — African-American patients with non-small cell lung cancer are just as likely to display an epidermal growth factor receptor (EGFR) mutation in tumors as Caucasians, which suggests they are as likely to benefit from targeted therapies such as erlotinib.

Method to detect bladder cancer earlier is under development

DENVER — Scientists may have discovered a way to diagnose bladder cancer at its earliest and, therefore, most treatable stages by measuring the presence or absence of microRNA using already available laboratory tests.

"Measuring expressions of microRNA in bodily fluid represents a very promising tool with widespread implications for screening," said Liana Adam, M.D., Ph.D., assistant professor in urology at The University of Texas MD Anderson Cancer Center.

c-Met may be a biomarker for metastatic hepatocellular carcinoma

DENVER — Targeting c-Met may be a promising personalized treatment method for approximately 45 percent of patients with hepatocellular carcinoma (HCC) who have c-Met-positive tumors, according to study results presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.

HCC is the most common primary malignant tumor of the liver; c-Met is a receptor for hepatocyte growth factor that appears to drive liver cancer growth, invasion and metastasis.